Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma
Clinical trial NCT01491672 · COMPLETED
Trial details
- NCT number
- NCT01491672
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2015-05-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.